Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Anesthesiology
    • Brain Death Revisited:...

    Brain Death Revisited: Dr Rahul Pandit

    Written by Anjali Nimesh Nimesh Published On 2018-04-30T19:03:34+05:30  |  Updated On 30 April 2018 7:03 PM IST
    Brain Death Revisited: Dr Rahul Pandit

    Brain Death is defined as the irreversible loss of all functions of the brain, including the brainstem. The three essential findings in Brain Death are Coma, the absence of Brainstem Reflexes, and Apnoea. An evaluation of Brain Death should be considered in patients who have suffered a massive, irreversible brain injury from an identifiable cause. A patient determined to be Brain Dead is legally and clinically dead. There is a clear difference between severe brain damage and Brain Death; Brain Death is the principal prerequisite for the donation of organs for transplantation. The 1994 Transplantation of Human Organ Act defines brain stem death in India, as opposed to the whole brain dead in many countries like the United States.


    Evolution of Brain Stem Death


    Historically, death was defined by the presence of putrefaction or decapitation, failure to respond to painful stimuli or the apparent loss of observable cardiorespiratory action. The widespread use of mechanical ventilators that prevent respiratory arrest has transformed the course of terminal neurologic disorders. Vital functions can now be maintained artificially after the brain has ceased to function. In 1968, an ad-hoc committee at Harvard Medical School reexamined the definition of Brain Death and defined irreversible coma, or brain death, as unresponsiveness and lack of receptivity, the absence of movement and breathing, the absence of brain-stem reflexes, and coma whose cause has been identified.


    Brain Death Certification


    Prerequisites:

    (1) Identification of history or physical examination findings that provide a clear etiology of brain dysfunction.


    The determination of Brain Death requires the identification of the proximate cause and irreversibility of Coma. Severe head injury, Hypertensive Intracerebral Hemorrhage, Aneurysmal Subarachnoid Hemorrhage and Hypoxic-ischemic Brain Insults are potential causes of irreversible loss of brain stem function.


    The evaluation of a potentially irreversible coma should include, as may be appropriate to the particular case; clinical or neuro-imaging evidence of an acute CNS catastrophe that is compatible with the clinical diagnosis of brain death.


    (2) Exclusion of any condition that might confound the subsequent examination of cortical or brain stem function.




    • Shock or Hypotension

    • Hypothermia with temperature < 32°C

    • Drugs are known to alter Neurologic, Neuromuscular function and Electroencephalographic testing, like Anaesthetic agents, Neuroparalytic drugs, Methaqualone, Barbiturates, Benzodiazepines, high dose Bretylium, Amitryptiline, Meprobamate, Trichloroethylene, alcohols.

    • Brain stem encephalitis

    • Guillain- Barre syndrome

    • Encephlopathy associated with Hepatic Failure, Uraemia, and Hyperosmolar Coma

    • Severe Hypophosphatemia


    Brain Death Examination


    Test all the three components of coma, loss of brain stem reflexes and Apnoea.


    Before starting to ensure the following




    • Pre Oxygenation with 100% Oxygen for 15 min.

    • Core temperature ≥ 36.5°C or 97.7°F

    • Euvolemia- positive fluid balance in the previous 6 hours

    • Normal PCO2 - arterial PCO2 ≥ 40 mm Hg

    • Normal PO2 - pre-oxygenation to arterial PO2 ≥ 200 mm Hg


    Demonstration of Coma




    • The absence of movement/ grimace to central deep painful stimuli in cranial nerve distribution Supraorbital Ridge, Temporo – Mandibular Joint (afferent V and efferent VII) or Trapezes Muscle squeeze (afferent and efferent spinal accessory nerve)

    • Painful stimuli in spinal dermatome distribution will not test response to central pain

    • The patient may have spinal reflexes present in brain stem death


    The absence of Brain Stem Reflexes




    • Pupils- no response to bright light Size: mid-position (4 mm) to dilated (9 mm) (absent light reflex - cranial nerve II and III)

    • Ocular movement- cranial nerve VIII, III and VI

    • No Oculocephalic Reflex (testing only when no fracture or instability of the cervical spine or skull base is apparent)

    • No deviation of the eyes to irrigation in each ear with 50 ml of cold water (tympanic membranes intact; allow 1 minute after injection and at least 5 minutes between testing on each side)

    • Facial sensation and facial motor response

    • No corneal reflex (cranial nerve V and VII)

    • No jaw reflex (Cranial Nerve IX)

    • Pharyngeal and tracheal reflexes (cranial nerve IX and X)

    • No response to stimulation of the posterior pharynx

    • No cough response to Tracheobronchial suctioning


    Demonstration of Apnoea.




    • Complete monitoring and disconnect the ventilator

    • Deliver 100% O2, 6 l/min, into the trachea. Option: place a cannula at the level of the carina.

    • Look closely for any respiratory movements (abdominal or chest excursions that produce adequate tidal volumes).

    • Measure arterial PO2, PCO2, and pH after approximately 8 minutes and reconnect the ventilator

    • If respiratory movements are absent and arterial PCO2 is ≥ 60 mm Hg (option: in carbon dioxide retainers 20 mm Hg increase in PCO2 over a baseline PCO2 ), the apnoea test result is positive (i.e. it supports the diagnosis of brain death)

    • If respiratory movements are observed, the apnoea test result is negative (i.e. it does not support the clinical diagnosis of brain death)

    • Connect the ventilator, if during testing

    • the systolic blood pressure becomes < 90 mm Hg (or below age-appropriate thresholds in children less than 18 years of age)

    • or the pulse oximeter indicates significant oxygen desaturation,

    • or cardiac arrhythmias develop;

    • Immediately draw an arterial blood sample and analyze arterial blood gas.

    • If PCO2 is ≥ 60 mm Hg or PCO2 increase is ≥ 20 mm Hg over baseline normal PCO2, the apnoea test result is positive (it supports the clinical diagnosis of brain death).

    • if PCO2 is < 60 mm Hg and a PCO2 increase are < 20 mm Hg over baseline normal PCO2, the result is indeterminate and a confirmatory test can be considered. (not allowed in |Indian law)


    When two doctors either Neurologist, Intensivist, Anesthesiologist or Physician who are nominated by appropriate authority, perform the test independently at least 6 hours apart, and if both tests are positive for brain death, the patient is declared as Brain Dead. The complete process is also observed by a primary admitting doctor of the patient and the hospital head, who along with the two doctors complete the Form 10 and certify death. The time of death is the end of second apnoea test.


    Once death is declared the next of kin of patent are informed and counselling for organ donation should be done.


    The author Dr Rahul Pandit is Director of Intensive Care at Fortis Hospital, Mulund.

    benzodiazepinesBrain Deathbrain dysfunctionbrain stem functionbrain stem reflexeBretyliumcarbon dioxidecomaDr Rahul PanditFortis hospitalhead injuryhemorrhageintensive careMeprobamateMethaqualoneNeuroparalytic drugsRahul PanditSevere head injuryTrichloroethylene

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok